证券记录 · 已归档季度
RMD
ResMed Inc. · Healthcare · Medical - Instruments & Supplies
15被追踪持有人
—Δ持有人
5.93M持有股份
$1.13B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 159 | +2 | 76.69M | $14.96B | +7 | −4 |
| Q1 2026 | 159 | +3 | 74.11M | $16.62B | +5 | −3 |
| Q4 2025 | 155 | -2 | 83.70M | $20.16B | +1 | −2 |
| Q3 2025 | 21 | 0 | 49.43M | $13.53B | — | −1 |
| Q2 2025 | 19 | +1 | 44.83M | $11.56B | +1 | — |
| Q1 2025 | 15 | -1 | 12.96M | $2.90B | — | −1 |
| Q4 2024 | 16 | -2 | 12.69M | $2.90B | — | −2 |
| Q3 2024 | 17 | +2 | 6.96M | $1.70B | +2 | — |
| Q2 2024 | 15 | — | 5.93M | $1.13B | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (被动) | 3.48M | — | $664.08M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 3.48M | — | $664.08M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Millennium Management ✦ | 436.06K | — | $83.47M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Norges Bank ✦ (被动) | 432.08K | — | $82.71M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 413.92K | — | $79.23M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 413.92K | — | $79.23M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Marshall Wace ✦ | 403.75K | — | $77.29M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 403.75K | — | $77.29M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 219.60K | — | $42.04M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 172.78K | — | $33.07M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 172.78K | — | $33.07M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 172.78K | — | $33.07M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 172.78K | — | $33.07M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 166.11K | — | $31.80M | 0.2% | n/c | 1 | SEC ↗ |
| 15 | Baillie Gifford ✦ | 52.56K | — | $10.06M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Baillie Gifford ✦ | 52.56K | — | $10.06M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Baillie Gifford ✦ | 52.56K | — | $10.06M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 44.20K | — | $8.46M | 0.1% | n/c | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 44.15K | — | $8.45M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Wellington Management ✦ | 44.15K | — | $8.45M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Fisher Asset Management ✦ | 25.16K | — | $4.82M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Arrowstreet Capital ✦ | 22.14K | — | $4.24M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 18.48K | — | $3.54M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 2.20K | — | $421,124 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 932 持有人, 96.37M 股份, $21.06B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 07
Farrell Michael J.
Officer, Director · 4.99K 股 · $1.03M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 07
SC 13G — AustralianSuper Pty Ltd
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据